A Multicenter, Randomized, Double-Blind Evaluation of the Efficacy of TJO-087 Versus 0.05% Cyclosporine A in Moderate to Severe Dry Eye
- 1 February 2023
- journal article
- research article
- Published by Mary Ann Liebert Inc in Journal of Ocular Pharmacology and Therapeutics
- Vol. 39 (1), 27-35
- https://doi.org/10.1089/jop.2022.0119
Abstract
Purpose: To compare the efficacy and ocular tolerability of a 0.08% nanoemulsion cyclosporine A (CsA) (TJO-087) once daily versus a conventional 0.05% emulsion CsA twice daily in dry eye disease. Methods: 178 patients with dry eye disease were randomly assigned to one of two groups: the TJO-087 or CsA0.05% group. Changes in the Ocular Surface Disease Index (OSDI), tear film break-up time (TBUT), corneal and conjunctival staining scores, and Schirmer test scores from baseline to the 32-week visit were compared between both groups. To evaluate ocular tolerability of the study formulations, 7 symptoms (stinging/burning, itching, blurred vision, sandiness/grittiness, dryness, light sensitivity, and pain or soreness) were evaluated (the higher the score, the lower the tolerability) at each follow-up visit. Results: A total of 155 eyes of 155 patients were enrolled. The TJO-087 and CsA0.05% groups showed significant improvement in OSDI, TBUT, ocular surface staining, and Schirmer test scores at 32 weeks from baseline. There was no difference in the extent of improvement in all efficacy parameters. There were no differences in the ocular tolerability scores between the 2 groups at all visits, except that the itching score was higher in the TJO-087 group than in the CsA0.05% group at week 8. Conclusion: Using topical 0.08% CsA once daily is an effective therapeutic option for improving the symptoms and signs in dry eye disease, with a tolerability comparable with that of conventional 0.05% CsA. This trial was registered at the US National Library of Medicine ClinicalTrials.gov (http://clinicaltrial.gov) as NCT05245604 (registration date: 19/06/2020).Keywords
This publication has 35 references indexed in Scilit:
- Diagnosing the severity of dry eye: a clear and practical algorithmBritish Journal of Ophthalmology, 2014
- A Novel Cyclosporin A Aqueous Formulation for Dry Eye Treatment: In Vitro and In Vivo EvaluationInvestigative Ophthalmology & Visual Science, 2012
- Successfully Improving Ocular Drug Delivery Using the Cationic Nanoemulsion, NovasorbJournal of Drug Delivery, 2012
- Usefulness of Double Vital Staining With 1% Fluorescein and 1% Lissamine Green in Patients With Dry Eye SyndromeCornea, 2011
- Topical Loteprednol Pretreatment Reduces Cyclosporine Stinging in Chronic Dry Eye DiseaseJournal of Ocular Pharmacology and Therapeutics, 2011
- Minimal Clinically Important Difference for the Ocular Surface Disease IndexJAMA Ophthalmology, 2010
- Adherence in Glaucoma: Objective Measurements of Once-Daily and Adjunctive Medication UseAmerican Journal of Ophthalmology, 2007
- Patients prefer once-daily glaucoma dropsAlbrecht von Graefes Archiv für Ophthalmologie, 2006
- Patient and Ophthalmologist Attitudes Concerning Compliance and Dosing in Glaucoma TreatmentJournal of Ocular Pharmacology and Therapeutics, 2004
- Two multicenter, randomized studies of the efficacy and safety of cyclosporine ophthalmic emulsion in moderate to severe dry eye diseaseOphthalmology, 2000